top of page

AstraZeneca & Kunsen: 2024 Hematology Challenge Finalist

Writer: Altum Sequencing
Altum Sequencing
Jun 4
1 min read

Selected as a finalist in the "Hematology Challenge" organized by AstraZeneca and Kunsen, an initiative dedicated to finding innovative solutions for clinical management in hematology. The company was recognized for its advanced software and genomic approach, aimed at optimizing diagnosis and monitoring for patients with blood cancers.



bottom of page